Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F0YD5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,786
Award facts
- Contract value 100% obligated
- $21,785.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $21,785.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of December 12, 2025. This non-competitive delivery order represents a single pharmaceutical procurement under AmerisourceBergen's existing contract vehicle with DLA. REPATHA (evolocumab) is a PCSK9 inhibitor used in cardiovascular disease management, typically prescribed to patients with high cholesterol who require additional therapeutic intervention beyond standard statins.
This delivery order is issued against AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. The award reflects AmerisourceBergen's established capability as a major federal pharmaceutical distributor, with the company demonstrating consistent competitiveness in open procurement processes across its extensive portfolio of medical product deliveries to federal health systems.
Quick answers
Who was awarded contract SPE2DR26F0YD5?
SPE2DR26F0YD5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26F0YD5 worth?
The government has obligated $21,786 on SPE2DR26F0YD5.
Is contract SPE2DR26F0YD5 an order under another contract?
Yes. SPE2DR26F0YD5 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0YD5 competed?
The extent of competition for SPE2DR26F0YD5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award